April Gary M 4

Accession 0000945769-12-000006

CIK 0000887497other

View on SEC.gov Company Profile

Filed

Jul 16, 8:00 PM ET

Accepted

Jul 17, 6:26 PM ET

Size

34.8 KB

Accession

0000945769-12-000006

Insider Transaction Report

Form 4

Period: 2012-07-13

HI TECH PHARMACAL CO INCHITK

April Gary M

President, HCP Division

Transactions

Exercise/Conversion
Common Stock
2012-07-13$5.83/sh+3,750$21,863→ 3,750 total
Exercise/Conversion
Common Stock
2012-07-17$22.25/sh+1,874$41,697→ 10,624 total
Sale
Common Stock
2012-07-17$32.41/sh−10,624$344,324→ 0 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-07-13−3,750→ 0 total
Exercise: $10.68From: 2009-01-29Exp: 2018-01-29→ Common Stock (3,750 underlying)
Sale
Common Stock
2012-07-13$29.54/sh−2,500$73,850→ 0 total
Sale
Common Stock
2012-07-13$29.15/sh−3,750$109,313→ 0 total
Exercise/Conversion
Common Stock
2012-07-17$19.59/sh+3,750$73,463→ 8,750 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-07-13−3,750→ 1,875 total
Exercise: $5.83From: 2009-11-13Exp: 2018-11-13→ Common Stock (3,750 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2012-07-17−5,000→ 0 total
Exercise: $23.99From: 2007-03-08Exp: 2016-03-08→ Common Stock (5,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2012-07-17−3,750→ 3,750 total
Exercise: $19.59From: 2010-11-12Exp: 2019-11-12→ Common Stock (3,750 underlying)
Exercise/Conversion
Common Stock
2012-07-13$10.68/sh+2,500$26,700→ 2,500 total
Sale
Common Stock
2012-07-13$29.35/sh−3,750$110,063→ 0 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-07-17−1,874→ 5,626 total
Exercise: $22.25From: 2011-11-10Exp: 2020-11-10→ Common Stock (1,874 underlying)
Exercise/Conversion
Common Stock
2012-07-13$10.68/sh+3,750$40,050→ 3,750 total
Exercise/Conversion
Common Stock
2012-07-17$23.99/sh+5,000$119,950→ 5,000 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-07-13−2,500→ 0 total
Exercise: $10.68From: 2008-02-02Exp: 2017-02-02→ Common Stock (2,500 underlying)
Award
Stock Option (Right to Buy)
2012-07-16+12,500→ 12,500 total
Exercise: $32.59From: 2013-07-16Exp: 2022-07-16→ Common Stock (12,500 underlying)

Footnotes (7)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.41 to 29.66, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (1), [2], [3] and (4) of this Form 4.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.26 to 29.46, inclusive.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.96 to 29.34, inclusive.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.10 to 32.65, inclusive.
[F5]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a 16b-3 Plan.
[F6]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 2009 Stock Option Plan, which is a 16b-3 Plan.
[F7]The option became or becomes exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

HI TECH PHARMACAL CO INC

CIK 0000887497

→

Entity typeother

Related Parties

filerCIK 0001463267

Filing Metadata

Form type: 4
Filed: Jul 16, 8:00 PM ET
Accepted: Jul 17, 6:26 PM ET
Size: 34.8 KB

View on SEC.gov